Zhangzhou Pientzehuang Pharmaceutical., Ltd

XSSC:600436 Stock Report

Market Cap: CN¥124.0b

Zhangzhou Pientzehuang Pharmaceutical Future Growth

Future criteria checks 2/6

Zhangzhou Pientzehuang Pharmaceutical is forecast to grow earnings and revenue by 14.8% and 11.9% per annum respectively. EPS is expected to grow by 14.7% per annum. Return on equity is forecast to be 21.1% in 3 years.

Key information

14.8%

Earnings growth rate

14.7%

EPS growth rate

Pharmaceuticals earnings growth17.8%
Revenue growth rate11.9%
Future return on equity21.1%
Analyst coverage

Good

Last updated22 Aug 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:600436 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202614,2884,2564,1764,06911
12/31/202512,7083,6593,6103,24912
12/31/202411,2373,1123,2653,04512
6/30/202410,6642,9781,1161,220N/A
3/31/202410,6003,0021,9682,104N/A
12/31/202310,0582,7972,0652,207N/A
9/30/20239,6782,8252,9183,082N/A
6/30/20239,3172,6992,7192,877N/A
3/31/20238,9752,5536,8107,001N/A
12/31/20228,6942,4726,6986,873N/A
9/30/20228,5262,4735,8505,989N/A
6/30/20228,5952,6315,4065,544N/A
3/31/20228,3682,556197289N/A
12/31/20218,0222,432370462N/A
9/30/20217,5532,354318627N/A
6/30/20217,1131,9227921,203N/A
3/31/20216,7981,7691,4231,842N/A
12/31/20206,5111,6721,0481,467N/A
9/30/20206,4511,594-727-520N/A
6/30/20206,0741,493-1,357-1,252N/A
3/31/20205,9521,438-1,153-1,075N/A
12/31/20195,7221,374-945-879N/A
9/30/20195,5221,3321,5441,626N/A
6/30/20195,2571,2721,5191,595N/A
3/31/20195,0281,221795870N/A
12/31/20184,7661,143538612N/A
9/30/20184,5551,0522679N/A
6/30/20184,365991113169N/A
3/31/20184,076907N/A641N/A
12/31/20173,714807N/A677N/A
9/30/20173,428730N/A794N/A
6/30/20173,101664N/A654N/A
3/31/20172,700616N/A549N/A
12/31/20162,309536N/A395N/A
9/30/20162,180575N/A407N/A
6/30/20162,032520N/A374N/A
3/31/20161,975497N/A342N/A
12/31/20151,886467N/A306N/A
9/30/20151,698513N/A330N/A
6/30/20151,503474N/A314N/A
3/31/20151,455440N/A298N/A
12/31/20141,454439N/A264N/A
9/30/20141,409373N/A240N/A
6/30/20141,446422N/A251N/A
3/31/20141,436438N/A289N/A
12/31/20131,396430N/A274N/A
9/30/20131,348423N/A217N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600436's forecast earnings growth (14.8% per year) is above the savings rate (2.9%).

Earnings vs Market: 600436's earnings (14.8% per year) are forecast to grow slower than the CN market (22% per year).

High Growth Earnings: 600436's earnings are forecast to grow, but not significantly.

Revenue vs Market: 600436's revenue (11.9% per year) is forecast to grow slower than the CN market (13.4% per year).

High Growth Revenue: 600436's revenue (11.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600436's Return on Equity is forecast to be high in 3 years time (21.1%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y